CRA Insights: A landscape assessment of newborn screening (NBS) in Europe
Newborn screening (NBS) has become an integral part of many public health programs.1 NBS programs have minimized patient suffering which results from extended...
Industries
Healthcare
CRA combines in-depth industry knowledge and cutting-edge analytics to evaluate issues being litigated and debated in the healthcare sector. Our industry knowledge enables us to explain, for example, the nuances of provider reimbursement or the patient incentives created by high deductible health insurance plans, and our economic, statistical, accounting, investigative, and finance skills—as well as our familiarity with key healthcare datasets—equips CRA to provide rigorous, defensible analyses tailored to the specific facts of a litigation or regulatory dispute.
Our experts have broad and deep experience in the healthcare sector including hospitals, physician practices, health insurance and health benefit plans, ACOs, PBMs, wholesalers, pharmacies, pharmaceuticals and biologicals, medical devices, clinical laboratories, dialysis facilities, ambulance transport, nursing homes, and home healthcare.
Engagements
- 01Investigating whistleblower allegations that hospital revenues had been materially overstatedThe audit committee of a large regional hospital needed immediate assistance, after receiving an anonymous whistleblower complaint.View engagement
- 02European Commission clears Cooper’s acquisition of Viatris’ European OTC businessThe transaction involved a number of horizontal overlaps in areas including antiseptics and disinfectants, laxatives, warts and corns, joint and muscular pain,...View engagement
- 03ITC Section 337 trial testimony on domestic industry for consumer wearable health monitoring technologyCRA’s Intellectual Property experts were retained by a global medical technology and consumer electronics company, to evaluate the economic prong of domestic...View engagement
Contact a Healthcare expert.
See all Healthcare expertsRecent events
2024 Annual Health Law Symposium
CRA is a proud sponsor of this event. Lori Lightfoot is the speaker for the session titled “Navigating the Transition: Implications of the CARES Act and ARPA...
2024 Why Antitrust? - Antitrust and Reproductive Choice Post-Dobbs
Monica Noether is a panelist during the session on protecting reproductive choice in healthcare and hospital mergers in a post-Dobbs world, part of the Why...